(Tuesday, 14 May 2013 10:40)
Piramal Enterprises today said it has received approval from the USFDA for its investigational new drug, P11187, that aims to target diabetes.
(Sunday, 05 May 2013 07:30)
Morgan Liscinsky, an FDA spokeswoman, said high levels of LDL cholesterol were a known risk factor for heart disease.
(Friday, 03 May 2013 11:07)
The ability to encapsulate potent drugs in tiny particles measuring billionths of a metre in diameter is opening up new options for super-accurate drug delivery
(Thursday, 11 April 2013 05:45)
Bill Clinton praised Indian generic drug companies such as Ranbaxy and Cipla for their stellar contribution in the fight against HIV/AIDS.
(Wednesday, 20 March 2013 05:25)
The seizure affects only the syrup that contains codeine phosphate, a narcotic substance commonly used in preparation of cough syrup.
(Sunday, 10 March 2013 06:31)
The agreement stipulates that Kose will focus on the Indian market through the JVC for manufacturing and selling cosmetics in India.
(Friday, 08 March 2013 10:42)
Out of the total analyst recommendations, 5 are buy and one is a sell. The average target price is Rs 530 - 22% more from the current market price.
(Thursday, 28 February 2013 23:27)
The purchase values Agila at 18.7 times December 2012 operating profit of $86 million and seven times its sales of $255 million.
(Wednesday, 27 February 2013 08:56)
The estimated sales in 2012 as per IMS for Doxepin Hcl, which falls in the neuropsychiatry segment, was $15.5 million, as per company.
(Monday, 25 February 2013 11:18)
The company has now 76 approvals and has so far filed 172 abbreviated new drug applications since the filing process began in 2003-04, it added.
(Thursday, 14 February 2013 23:30)
In 2009, Mylan and Biocon had come together to develop five blockbuster biologic drugs in cancer and pain areas.
(Tuesday, 29 January 2013 20:31)
Israel-based Teva Pharmaceuticals, an $18 billion generic drug maker will set up OTC medicine facility in Gujarat in collaboration with Procter & Gamble.
(Monday, 14 January 2013 23:29)
“India is an under-diagnosed market, so the argument that less people are falling sick might not be true,” asserts Sujay Shetty, head of life sciences, PwC.
(Sunday, 13 January 2013 09:05)
'Besides inorganic initiatives, the industry is also stepping up its organic investments.'
(Wednesday, 02 January 2013 08:36)
US Food and Drug Administration provided marketing approval to its partner in US, Salix Pharmaceuticals, for Crofelemer 125 mg delayed-release tablets.